ICP incidence at nearly 3% worldwide, but varies by region: Study
Intrahepatic cholestasis of pregnancy was estimated to affect 2.9% of women globally, with highest numbers in Asia and lowest in Oceania.| Liver Disease News
Intrahepatic cholestasis of pregnancy was estimated to affect 2.9% of women globally, with highest numbers in Asia and lowest in Oceania.| Liver Disease News
Nesfatin-1 (NF-1), a hormone that may ease cellular stress, reduced injury to the placenta in a mouse model of ICP, a study found.| Liver Disease News
A combination of skin and liver problems in young people may be indicative of an EPP diagnosis, according to a case report.| Porphyria News
Mitochondrial problems may contribute to cholestasis-related liver damage and represent a potential therapeutic target, a study reports.| Liver Disease News
A genetic disease, Alagille syndrome can cause a wide range of symptoms, including liver problems, and affects about 1 in 30,000 newborns.| Liver Disease News
A range of treatment options, including medications and procedures, are available for managing Alagille syndrome symptoms.| Liver Disease News
Common symptoms of cholestasis, a condition affecting the flow of bile from the liver, include jaundice and itchy skin.| Liver Disease News
